poisar

Stocks · News reference

Kazia Therapeutics Announces Two Abstracts Accepted for 2026 San Antonio Breast Cancer Symposium

Fiscal.ai

Kazia Therapeutics has received acceptance for two research abstracts regarding its lead candidate, paxalisib, for poster presentation at the 2026 San Antonio Breast Cancer Symposium.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading